Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

Ospomyv, Xborso

Australian Public Assessment Report

AusPAR

AusPAR: Ospomyv, Xborso [PDF, 1.46 MB]

AusPAR: Ospomyv, Xborso [DOCX, 4.86 MB]

Attachment: Product information for Ospomyv [PDF, 436.85 KB]

Attachment: Product information for Ospomyv [DOCX, 198.15 KB]

Attachment: Product information for Xborso [PDF, 513.11 KB]

Attachment: Product information for Xborso [DOCX, 642.34 KB]

Device/Product Name

Ospomyv, Xborso

Active ingredients

Denosumab

AusPAR Date

5 February 2026

Published

12 February 2026

Submission Number

PM-2024-01517-1-5

Submission Type

New biosimilar entity

Decision

Approved

Product types

Prescription medicines